Extending thrombolysis to 4·5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data (2019) Johnston C, Burns R, McNeil J, Tress BM, Campbell BC, Williams M, Ma H, et al. Journal article Three-dimensional visualisation of the fetal heart using prenatal MRI with motion-corrected slice-volume registration: a prospective, single-centre cohort study (2019) Lloyd DF, Pushparajah K, Simpson JM, van Amerom JF, van Poppel MP, Schulz A, Kainz B, et al. Journal article Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial (2019) Herrlinger U, Tzaridis T, Mack F, Steinbach JP, Schlegel U, Sabel M, Hau P, et al. Journal article Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. (2018) van der Valk MJ, Hilling DE, Bastiaannet E, Meershoek-Klein Kranenbarg E, Beets GL, Figueiredo NL, Habr-Gama A, et al. Journal article Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data (2018) Oikonomou EK, Desai MY, Mancio J, Alashi A, Centeno EH, Thomas S, Herdman L, et al. Journal article International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study (2018) Pages F, Mlecnik B, Marliot F, Bindea G, Ou FS, Bifulco C, Lugli A, et al. Journal article Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial (2018) Azizi M, Schmieder R, Mahfoud F, Weber MA, Daemen J, Davies J, Basile J, et al. Journal article Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial (2017) Langdahl BL, Libanati C, Crittenden DB, Bolognese MA, Brown JP, Daizadeh NS, Dokoupilova E, et al. Journal article Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study (2017) Feagan BG, Sandborn WJ, D'Haens G, Panes J, Kaser A, Ferrante M, Louis E, et al. Journal article Pathogenetic insights from the treatment of rheumatoid arthritis (2017) McInnes IB, Schett G Journal article